Orthobiologics market to reach $10.1B by 2025 — 6 key market players


The global orthobiologics market is projected to reach $10.1 billion by 2025, according to Market Insights Reports.

The viscosupplementation products segment accounted for the greatest market share in 2017, which is largely attributed to increasing rates of knee and hip joint osteoarthritis among the baby boomer population and decreasing viscosupplementation costs.

Leading market players include:

1. Bone Biologics

2. Medtronic

3. Bioventus

4. Pioneer Surgical Technology

5. Smith & Nephew

6. Stryker

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Webinars

Featured Whitepapers